Clinical Trial Update: HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants [Phase 2]

View source ↗

Summary

Phase II trial assessing safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine followed by a recombinant adenoviral vector HIV-1 vaccine boost in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• VRC-HIVDNA016-00-VP
• VRCHIVADV014-00-VP

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED